"Improving Health, Reducing Costs, Saving Lives We are revolutionizing health and improving drug adherence through large data analytics sent through blockchain"
Curaizon
Improving Health
CuraServe ™ is a complete healthcare ecosystem that improves drug compliance and provides benefits that change the game for patients and healthcare providers. We use a series of outreach tools and messages, supported by predictive modeling and behavioral analysis, to improve drug adherence levels. Because our CuraServe ™ solution helps patients, it also generates large amounts of patient data. The data is then anonymized and available through CuraData ™. The only way pharmaceutical companies, academics, and researchers can access this data by purchasing CuraTokens ™.
About Curaizon
We solve real-world problems enormously by helping patients take their medications properly
- Every day, millions of people fail to take their medication as determined and the personal and financial costs generated are staggering. Worldwide, noncompliance generates $ 700 billion in medical costs that can be avoided.
- The data we create are unique and have tremendous value for pharmaceutical companies, researchers, and governments.
- Whenever a patient uses our CuraServe technology, our data grows in utility and value.
- Curaizon ™ solves the problem of drug non-compliance by spreading our technology through national health services. As part of our solution, we collect full anonymous data about how and when patients take medication.
- CuraTokens ™ is the only way to access our data. Tokens can be exchanged for data access, which will advance medical research, lower health care costs and save lives.
- The value of CuraToken ™ is based on real solutions to real problems.
Curaizon
- Improving Health
- Reducing Costs & Saving Lives
Problem
Drugs are our most cost-effective health intervention and represent the first line of defense against chronic and long-term conditions. Unfortunately, too many people fail to take their medications properly and the resulting personal and financial costs are staggering. Despite the world's recognition of the seriousness of the issue (also called drug disobedience), there have been no significant changes over the last 30 years.
- Drug obedience worldwide generates about $ 700 billion in additional health care costs.
- Pharmaceutical companies lose more than $ 630 billion in revenues annually for noncompliance and the amount lost by 13% per year.
Solution
CuraServe [tm] is a complete healthcare ecosystem that improves drug compliance and brings benefits that change the game for patients and healthcare providers. We use a series of outreach tools and messages, supported by predictive modeling and behavioral analysis, to improve drug adherence levels. Because our CuraServe [tm] solution helps patients, it also generates large amounts of patient data. The data is then anonymized and available via CuraData [tm]. The only way pharmaceutical companies, academics, and researchers can access this data by purchasing CuraTokens [tm].
Our data is the first-of-its kind insight into the behavior and compliance of real-time patients. CuraData [tm] will ultimately provide the healthcare and pharmaceutical industry the tools they are looking for to bring about the changes that the patient needs. Our value-based approach to simple, accessible, but valuable data exchange and analysis will revolutionize health care.
Health care is changing forever and CuraServe [tm] stands on the cutting edge of this transformation.
Curaizon [tm] is a UK-based company that has developed CuraServe [tm].
Market
The total number of potential users of our platform includes all the patients covered by national health services worldwide. It is a total of 1.4 billion patients and continues to grow.
Social benefits
- Life is Better
- Better Research
- Better Health
- Money Saved
Curaizon ™ ecosystem
ROADMAP
TEAM
Our team combines passion, innovation, and expertise with experience in health, finance, operations, marketing, and technology
LEADERSHIP
Nicholas James Rumble
Chief Executive Officer (CEO)
Nicholas has a background in mathematics and economics and spent much of his working life in investment banking. Most recently he was responsible for Saxo Bank's Asia Pacific and Australasian operations. He was heavily engaged in both retail and institutional client relationships and was instrumental in pioneering new trading technologies. He brings more than 20 years of business experience and knows how to bring great teams of people together and execute high-level plans; especially where technology plays a key role.
Chris Matey
Chief Operations Officer (COO)
Chris has an MBA in finance as well as a JD. He has experience as a financial analyst, director and executive as well as an experienced entrepreneur as well as an entrepreneur. In his roles at OrderTrust ™ and CyberCash ™ he developed high-volume payment related products deployed around the world. In his work as a consultant he has worked with a variety of companies around the world providing strategic analysis and fundraising support.
Mark Nathan
Chief Financial Officer (CFO)
Mark Nathan is a chartered accountant has been working with Curaizon since 2015. He has high-level experience in business operations across multiple sectors. His systems for comparing performance and costs against budget / forecasting and extracting volume / mix variances in relation to the model's revenues to assess 'top-line' profitability have been deployed multiple times. Mark's focus has been on the control of the costs across the business, through the annual budgeting process, and a quarterly re-forecasting program.
Darran Trute
Chief Technology Officer (CTO)
Darran has delivered a range of IT solutions for clients ranging from blue chip companies to not for profits. He currently specializes in blockchain related projects providing technical expertise to address real world issues. Darran also has extensive experience in pioneering health sector redesign to meet the demands of an aging population with multiple, complex health needs.
Luke Lerdal
Chief Data Officer (CDO)
Luke has an extensive background in data modeling and systems. He has led complex data analysis projects with an emphasis on big data. His responsibilities include overseeing the data integration and data structure of CuraServe ™ and CuraData ™.
BUSINESS DEVELOPMENT
Andrey Verbitsky
Tokenomics Expert
Andrey has designed more than 80 tokens and is expert considered a leading expert in token economics and crypto-currencies. He has consulted across a range of industries, advising on ICO's and blockchain application strategies to drive business impact and bring value to investors, founders, and end users.
He brings enforcement experience in technology, economics and behavioral science with over 20 years' experience in telecommunications, product management and consulting, working with multiple Tier 1 clients across the globe.
Pencho Gavazov
Director of Business Development
Pencho has a background in Innovation and entrepreneurship. His experience as a marketing manager and business development consultant had positioned him well within the international business environment. A substantial amount of his work experience is within the health sector where he has been successful in market acquisition activities by expanding sales across four continents. One of his top achievements is within strategic development where he successfully established co-branding partnership with Tracoe, the world's leading manufacturer of medical devices within the field of tracheotomy. Pencho has been working with Curaizon ™ since it started in 2015.
Kristaps Kuhalskis
Creative Director
Kristaps has a masters in both international business and innovation and entrepreneurship as well as advanced degrees in multimedia design & communication. He has work experience in global branding, marketing and communication strategy and execution, project management, multimedia development and human resources. His experience includes working at a leading global market research firm, industrial manufacturing, technology start-ups and his own creative agency. Kristaps creative mindset, coupled with his ability to work in diverse country and cultural environments, are a great asset for the team.
ADVISORS
Dr. Rory McCrea
MB BS, MSc, MRCGP
Rory has been described by the UK's Financial Times as a "Health Entrepreneur". He gained this reputation for his farsighted innovation as Chairman of ChilversMcCrea Healthcare, co-founding and overseeing, from startup in 2001 through to NHS General Partner and Urgent Care Services across England and Wales. Rory has been highly influential in the public sector having been a Medical Director with NHS West Essex for over a decade before becoming Director of Clinical Transformation with The West Essex Clinical Commissioning Group. Rory will be a driving force behind the adoption of Curaizon's technology across multiple national healthcare services. Rory has been an advisory board member of Curaizon's ™ since 2015.
Sarah Chilvers
BSc, RGN, RHV, MBA, DProf
Sarah has spent her life working in, and with, the UK's National Health Service. First as a registered nurse and a health visitor and then in NHS management. Sarah went on to complete her Professional Doctorate at The Middlesex University in 2004, specializing in how to deliver innovative and clinical excellence for more than 25 years. Winner of the Laing and Buisson Independent Healthcare Award in 2008 for Entrepreneurial Achievement, Sarah has a perfect mix of clinical and business experience that has proven invaluable in her advisory role at Curaizon ™ since 2015. She is responsible for integrating our clinical trials and the adoption of our national health services.
Parexel
Biopharmaceutical service provider
Parexel International is a global provider of biopharmaceutical services. It conducts clinical trials on behalf of its clients to expedite the approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the top-selling 200 biopharmaceuticals on the market today. Parexel are our clinical trial partners in the UK and will deliver bridging studies for entry into each new territory.
TECHNOLOGY
ICO Campaign Partner
ICOBOX is the first and the biggest new generation Blockchain Growth Promoter and Business Facilitator for companies seeking to sell their products via ICO crowdsales.
Gateway Technolabs
Software Development
A global information technology services, solutions and product engineering company with a team of brilliant and dedicated professionals serving our customers across 30 countries in 5 continents.
Innohead
Big Data & Predictive Analytics
A Big Data and Predictive Analytics company focused on data mining and customer analytics.
Timengo
IoT, Cloud and security experts
Timengo are IoT, Cloud and security experts with a wealth of knowledge and experience within the healthcare sector. They drive our internal and external technology applications and help us to deliver secure API infrastructure with external databases.
CLX
Tier-1 CPaaS provider
CLX are the only tier-1 CPaaS provider trusted to carry over 25 billion transactions per year and are our partner partner.
For more information link below:
Website: https://curatoken.curaizon.com/
Twitter: https://twitter.com/curaizon
Author by: Dava.Dina
ETH: 0x6A9b4B19f04d46acB112fd999d8d2cD07938D3C2
